Cart
sales@molnova.com
Fasoracetam
CAS No. 110958-19-5
Fasoracetam( —— )
Catalog No. M22030 CAS No. 110958-19-5
Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 111 | In Stock |
|
| 50MG | 167 | In Stock |
|
| 100MG | 248 | In Stock |
|
| 200MG | 357 | In Stock |
|
| 500MG | 601 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFasoracetam
-
NoteResearch use only, not for human use.
-
Brief DescriptionFasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
-
DescriptionFasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110958-19-5
-
Formula Weight196.25
-
Molecular FormulaC10H16N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1273.89 mM)
-
SMILESO=C([C@H]1CCC(=O)N1)N1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Elia J , Ungal G , Kao C , et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling[J]. Nature Communications, 2018, 9(1).
molnova catalog
related products
-
D3-βArr
D3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.
-
Corynoxeine
Corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty.
-
Dibenzylamine
Dibenzylamine is a part of potent neurogenic agent.
